moa glp 1 agonist Frontiers Frontiers | Exploring the multifaceted

1992;286(Pt 2):31330

doi: 10.1021/acs.jmedchem.7b00174 79 NestorJJZhangXJaw-TsaiSParkesDGBeckerCK

10.1097/aln.0000000000004381

Saldvar-Gonzlez, G

Listed Products of GLP-1 Receptor Agonists (GLP-1RA) At present, 9 GLP-1 receptor agonist hypoglycemic drugs have been approved for marketing in the world, namely: exenatide, liraglutide, Exenatide extended-release (exenatide ER), albiglutide, dulaglutide , lixisenatide, benaglutide, semaglutide, polyethylene glycol loxenatide injection and oral semaglutide

Many clinicians recommend prioritizing protein and protein supplements, a high-quality multivitamin, magnesium, electrolytes, and omega-3 fatty acids